Last reviewed · How we verify
NCT04563481
Effectiveness of Telerehabilitation on Scleroderma
NA trial testing Hand Therapy via Telerehabilitation in Scleroderma in 32 participants. Status unknown.
1 November 2023
Quick facts
| Lead sponsor | Istanbul University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 May 2022 |
| Primary completion | 1 November 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Hand Therapy via Telerehabilitation
- Hand Therapy by Physiotherapist
Conditions studied
- Scleroderma — all drugs for Scleroderma →
- Scleroderma, Systemic — all drugs for Scleroderma, Systemic →
- Scleroderma Associated Digital Ulcer — all drugs for Scleroderma Associated Digital Ulcer →
- Hand Rheumatism — all drugs for Hand Rheumatism →
Sponsor
Istanbul University
Who can join
Adults 18 to 55, any sex, with Scleroderma or Scleroderma, Systemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The effects of exercises performed by telerehabilitation on individuals with hand-affected scleroderma on range of motion, grip strength, function, sensation, daily life activities and general health will be compared with the effects of traditional physiotherapy practices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04563481
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hand Therapy via Telerehabilitation
Trials testing the same drug.
- NCT04684225 — Telerehabilitation on Hand-Affected Scleroderma · NA · completed
Other recruiting trials for Scleroderma
Currently open trials in the same condition.
- NCT07292961 — Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed Wi · NA · recruiting
- NCT06801119 — Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） · Phase 1 · recruiting
- NCT06554132 — Respiratory Muscle Strength and Aerobic Capacity in Scleroderma · recruiting
- NCT03800017 — Skeletal Muscle Function in Interstitial Lung Disease · NA · recruiting
- NCT06598982 — Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis · recruiting
Other Istanbul University trials
Trials by the same sponsor.
- NCT07472946 — Whole-Body Vibration Exercise in Patients With Parkinson's Disease · NA · not yet recruiting
- NCT07433894 — Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis · not yet recruiting
- NCT07420049 — Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study · not yet recruiting
- NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
- NCT07473024 — pEEG-Guided Anesthesia and Behavioral Outcomes in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04563481 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul University
- Last refreshed: 13 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04563481.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing